Effect of codeine on gastrointestinal motility in relation to CYP2D6 phenotype

Clinical Pharmacology and Therapeutics

Volumn 61, Issue 4, 1997, Pages 459-466

  Mikus, G ^a   Trausch, B ^a   Rodewald, C ^a   Hofmann, U ^a   Richter, K ^a   Gramatte, T ^a   Eichelbaum, M ^a  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; DRUG METABOLITE; MORPHINE; PLACEBO; SALAZOSULFAPYRIDINE; SPARTEINE; SULFAPYRIDINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EXCRETION; DRUG METABOLISM; DRUG URINE LEVEL; ENZYME ACTIVITY; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030948340     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(97)90196-X     Document Type: Article

References (33)